Rare Disease news

Rare Diseases Today—April 23, 2026

This week’s Rare Diseases update highlights late-stage clinical progress,…


Immunology

Immunology Today—April 15, 2026

This week’s Immunology update highlights regulatory progress, clinical…


Onco_background

Oncology Today—April 6, 2026

This week’s Oncology update highlights regulatory progress, late-stage clinical…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Syneron Bio completion of $150 million Series B

Lucid Diligence Brief: Syneron Bio completion of $150 million Series B…


Cardiovascular

Cardiovascular Today—April 2, 2026

This week’s Cardiovascular update highlights regulatory approvals, device…


Cell_Gene_Therapy

Cell and Gene Therapy Today—April 2, 2026

This week’s Gene and Cell Therapy update highlights regulatory progress,…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: AstraZeneca's tozorakimab meets primary endpoint in COPD

Lucid Diligence Brief: AstraZeneca's tozorakimab meets primary endpoint in……


Onco_background

Oncology Today—March 23, 2026

This week’s Oncology update highlights EU regulatory expansion, late-stage…


Women's_Health

Women’s Health Today—March 18, 2026

This biweekly Women’s Health update highlights regulatory momentum, late-stage…


Immunology

Immunology Today—March 18, 2026

This week’s Immunology update highlights regulatory progress, late-stage…


Onco_background

Oncology Today—March 16, 2026

This week’s Oncology update highlights regulatory progress, pivotal-intent…


Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap—March 11, 2026

This biweekly AI in Healthcare and Digital Health video recap highlights safety…


Privacy Preference Center